Work

444TiP Trial in progress: A phase Ib study of sotorasib, a selective KRAS G12C inhibitor, in combination with panitumumab and FOLFIRI in treatment naïve and previously treated metastatic colorectal cancer (CodeBreaK 101)

Year: 2022

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2022.07.1865

Authors: T. Masuishi, Y. Kuboki, M.G. Fakih, J.H. Strickler, M. Furqan, E.J. Kim, P. Cardona, Q. Tran, E. Chan, D.S. Hong

Institutions: Aichi Cancer Center, Aichi Cancer Center Hospital, National Cancer Center Hospital East, City Of Hope National Medical Center, City of Hope, Duke Medical Center, University of Iowa, University of California Davis Medical Center, UC Davis Comprehensive Cancer Center, Amgen (United States), The University of Texas MD Anderson Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Merck, Novartis, AbbVie

OpenAlex ID: W4295837306

FWCI: 0.418

Cites: 2

Cited by: 4

Related to: 10